Zuranolone: A Breakthrough in the Treatment of Postpartum Depression

被引：0
|
作者：
Diaz, Zobeida M. [1 ,2 ,4 ]
Adashi, Eli Y. [3 ]
机构：
[1] Brown Univ, Dept Psychiat & Human Behav, Warren Alpert Med Sch, Providence, RI USA
[2] Care New England Hlth Syst, Women & Infants Hosp, Ctr Womens Behav Hlth, Dept Med, Providence, RI USA
[3] Brown Univ, Dept Med Sci, Med & Biol Sci, Providence, RI USA
[4] Brown Univ, Women &Infants Hosp, Ctr Womens Behav Hlth, Warren Alpert Med Sch,Dept Psychiat & Human Behav, 2 Dudley St,1st Floor, Providence, RI 02905 USA
来源：
JOURNAL OF WOMENS HEALTH | 2024年 / 33卷 / 04期
关键词：
D O I：
10.1089/jwh.2023.0991
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
[No abstract available]
引用
收藏
页码：407 / 408
页数：2
相关论文
共 50 条
  • [21] Breakthrough in the Treatment of Depression
    不详
    FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2013, 81 (07) : 363 - 363
  • [22] Zuranolone for postpartum depression: a systematic review and meta-analysis of two randomized studies
    Oliveira, Juliana Almeida
    Eskandar, Karine
    Freitas, Marcos Aurelio Araujo
    Philip, Chris Elizabeth
    REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA, 2024, 46
  • [23] FDA-Approved Zuranolone: First Oral Treatment for Postpartum Depression, Ushering in a New Era of Hope; A Narrative Review
    Haris, Muhammad
    Mukhtar, Sameen
    Mohiuddin, Mubashir
    Amir, Suhaina
    Laique, Fatima
    Azam, Muhammad Mazhar
    Giri, Bibek
    HEALTH SCIENCE REPORTS, 2025, 8 (03)
  • [24] Zuranolone Treatment for Depression: Steady Progress in Mechanism-Focused Therapeutics?
    Pine, Daniel S.
    AMERICAN JOURNAL OF PSYCHIATRY, 2023, 180 (09): : 631 - 633
  • [25] A Breakthrough Treatment for Major Depression
    Kripke, Daniel F.
    JOURNAL OF CLINICAL PSYCHIATRY, 2015, 76 (05) : E660 - E661
  • [26] Indirect comparisons of relative efficacy estimates of zuranolone and selective serotonin reuptake inhibitors for postpartum depression
    Meltzer-Brody, Samantha
    Gerbasi, Margaret E.
    Mak, Catherine
    Toubouti, Youssef
    Smith, Sarah
    Roskell, Neil
    Tan, Robin
    Chen, Shih-Yin
    Deligiannidis, Kristina M.
    JOURNAL OF MEDICAL ECONOMICS, 2024, 27 (01) : 582 - 595
  • [27] Clinical Efficacy of a 2-Week Treatment Course of Zuranolone for the Treatment of Major Depressive Disorder and Postpartum Depression: Outcomes From the Clinical Development Program
    Clayton, A.
    Cutler, A. J.
    Deligiannidis, K. M.
    Lasser, R.
    Sankoh, J.
    Doherty, J.
    Kotecha, M.
    EUROPEAN PSYCHIATRY, 2022, 65 : S97 - S98
  • [28] The efficacy and safety of Zuranolone for treatment of depression: A systematic review and meta-analysis
    Fayoud, Aya M.
    Orebi, Hisham Ahmed
    Elshnoudy, Iman Abdelhady
    Elsebaie, Mai Alaaeldin Temraz
    Elewid, Mariam Mahmoud Mohamed
    Sabra, Hamdy Khaled
    PSYCHOPHARMACOLOGY, 2024, 241 (07) : 1299 - 1317
  • [29] Concurrent Improvement of Depressive and Anxiety Symptoms in Patients With Postpartum Depression Treated With the Oral Neuroactive Steroid Zuranolone
    Deligiannidis, Kristina
    Werneburg, Brian
    Huang, Ming-Yi
    Suthoff, Ellison
    Lasser, Robert
    Gunduz-Bruce, Handan
    Acaster, Sarah
    Fridman, Moshe
    Bonthapally, Vijayveer
    Kanes, Stephen J.
    NEUROPSYCHOPHARMACOLOGY, 2020, 45 (SUPPL 1) : 229 - 230
  • [30] The efficacy of zuranolone versus placebo in postpartum depression and major depressive disorder: a systematic review and meta-analysis
    Winslow, Mackenzie
    White, Emily
    Rose, Suzanne J.
    Salzer, Elijah
    Nemec, Eric C.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2024, 46 (03) : 590 - 601
12345